Anixa Biosciences, Inc. (ANIX Quick QuoteANIX - Free Report) was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 56.2% in the past one-month time frame.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Anixa Biosciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

ANIXA BIOSCIENCES INC Price

ANIXA BIOSCIENCES INC price | ANIXA BIOSCIENCES INC Quote

A better-ranked stock in the Medical - Biomedical and Genetics industry is CSL Limited (CSLLY Quick QuoteCSLLY - Free Report) , which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by referendums and legislation, this industry is expected to blast from an already robust $17.7 billion in 2019 to a staggering $73.6 billion by 2027. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot stocks we're targeting >>